Human papillomavirus and breast cancer: No evidence of association in a spanish set of cases

Anticancer Research

Volumn 35, Issue 2, 2015, Pages 851-856

  Vernet Tomas, Maria ^a,b   Mena, Marisa ^c   Alemany, Laia ^c,d   Bravo, Ignacio ^c   De Sanjosé, Silvia ^c,d   Nicolau, Pau ^a   Bergueiro, Alba ^a   Corominas, Josep Maria ^a,b   Serrano, Sergi ^a,b   Carreras, Ramon ^a,b   Lloveras, Belen ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Breast cancer; Human papillomavirus; Polymerase chain reaction

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PARAFFIN; PROTEIN P53; PRIMER DNA; VIRUS DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL PROTOCOL; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENOTYPE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WART VIRUS; BREAST TUMOR; GENETICS; ISOLATION AND PURIFICATION; NETHERLANDS; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; SPAIN; VIROLOGY;

AGED; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NETHERLANDS; PAPILLOMAVIRIDAE; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; SPAIN;

EID: 84923648311     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D and Bray F: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49: 1374-1403, 2013.
2. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL, and Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378: 1461-1484, 2011.
3. Clèries R, Esteban L, Borràs J, Marcos-Gragera R, Freitas A, Carulla M, Buxó M, Puigdefábregas A, Izquierdo A, Gispert R, Galceran J and Ribes J: Time trends of cancer incidence and mortality in Catalonia during 1993-2007. Clin Transl Oncol 16: 18-28, 2014.
4. Pollán M, Pastor-Barriuso R, Ardanaz E, Argüelles M, Martos C, Galcerán J, Sánchez-Pérez MJ, Chirlaque MD, Larrañaga N, Martínez-Cobo R, Tobalina MC, Vidal E, Marcos, Gragera R, Mateos A, Garau I Rojas-Martín MD, Jiménez R, Torrella-Ramos A, Perucha J, Pérez-de-Rada ME, González S, Rabanaque MJ, Borràs J, Navarro C, Hernández E, Izquierdo A, López-Abente G and Martínez C: Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst 101: 1584-1591, 2009.
5. Joshi D and Buehring GC. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat 135: 1-15, 2012.
6. Malagón T, Drolet M, Boily M-C, Franco EL, Jit M, Brisson J and Brisson J: Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 781-789, 2012.
7. Alibek K, Kakpenova A, Mussabekova A, Sypabekova M and Karatayeva N: Role of viruses in the development of breast cancer. Infect Agent Cancer 8: 32, 2013.
8. Francis IM, Al-Ayadhy B, Al-Awadhi S, Kapila K and Al-Mulla F: Prevalence and correlation of human papilloma virus and its types with prognostic markers in patients with invasive ductal carcinoma of the breast in Kuwait. Sultan Qaboos Univ Med J 13: 527-533, 2013.
9. Hossein R, Behzad S, Tahar M and Azadeh NA: Prevalence of human papillomavirus genotypes associated with cervical and breast cancers in Iran. Monoclon Antib Immunodiagn Immunother 32: 399-403, 2013.
10. Liang W, Wang J, Wang C, Lv Y, Gao H, Zhang K, Liu H, Feng J, Wang L and Ma R: Detection of high-risk human papillomaviruses in fresh breast cancer samples using the hybrid capture 2 assay. J Med Virol 85: 2087-2092, 2013.
11. Pereira Suarez AL, Lorenzetti MA, Gonzalez Lucano R, Cohen M, Gass H, Martinez Vazquez P, Gonzalez P, Preciado MV and Chabay P: Presence of human papilloma virus in a series of breast carcinoma from Argentina. PLoS One 8: e61613, 2013.
12. Manzouri L, Salehi R, Shariatpanahi S and Rezaie P: Prevalence of human papilloma virus among women with breast cancer since 2005-2009 in Isfahan. Adv Biomed Res 3: 75, 2014.
13. Aceto GM, Solano AR, Neuman MI, Veschi S, Morgano A, Malatesta S, Chacon RD, Pupareli C, Lombardi M, Battista P, Marchetti A, Mariani-Costantini R and Podestà EJ: High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer. Breast Cancer Res Treat 122: 671-683, 2010.
14. Herrera-Goepfert R, Vela-Chávez T, Carrillo-García A, Lizano-Soberón M, Amador-Molina A, Oñate-Ocaña LF, and Hallmann RSR: High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women. BMC Cancer 13: 445, 2013.
15. The Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumors. Nature 490: 61-70, 2012.
16. De Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez, GAH, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SCB, Qiao YL, Lerma E, , Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, , Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel, Christine, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein JMuñoz N and Bosch FX: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective crosssectional worldwide study. Lancet Oncol 11: 1048-1056, 2010.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 64: 1-378, 1995.
18. Di Lonardo A, Venuti A and Marcante ML: Human papillo-mavirus in breast cancer. Breast Cancer Res Treat 21: 95-100, 1992.
19. Simões PW, Medeiros LR, Simões Pires PD, Edelweiss MI, Rosa DD, Silva FR, Silva BR and Rosa MI: Prevalence of human papillomavirus in breast cancer: a systematic review. Int J Gynecol Cancer 22: 343-347, 2012.
20. Glenn WK, Whitaker NJ and Lawson JS: High-risk human papillomavirus and Epstein Barr virus in human breast milk. BMC Res Notes 5: 477, 2012.
21. Nichols AC, Palma DA, Dhaliwal SS, Tan S, Theuer J, Chow W, Rajakumar C, Um S, Mundi N, Berk S, Zhou R, Basmaji J, Rizzo G, Franklin JH, Fung K, Kwan K, Wehrli B, Salvadori MI, Winquist E, Ernst S, Kuruvilla S, Read N, Venkatesan V, Todorovic B, Hammond JA, Koropatnick J, Mymryk JS, Yoo J and Barrett JW: The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population. Curr Oncol 20: 212-219, 2013.
22. Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E and Marth C: Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 31: 292-297, 2004.
23. Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M and Sweetland S: Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370: 1609-1621, 2007.
24. Yan X, Shah W, Li X and Wang Y: Estrogen contributes to non-pRb targeted HPV18 E7-caused cell proliferation and transformation. Cancer Biol Ther 9: 206-215, 2010.
25. Son J, Park JW, Lambert PF and Chung S-H: Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis 35: 489-496, 2014.
26. Li CI, Beaber EF, Tang M-TC, Porter PL, Daling JR and Malone KE: Reproductive factors and risk of estrogen receptor-positive, triple-negative, and HER2-neu-overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat 137: 579-587, 2013.
27. De Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R and Sastre-Garau X: No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109: 55-58, 2008.
28. Lindel K, Forster A, Altermatt HJ, Greiner R and Gruber G: Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 16: 172-177, 2007.
29. Bratthauer GL, Tavassoli FA and O'Leary TJ: Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Prac 188: 384-386, 1992.
30. Wrede D, Luqmani YA, Coombes RC and Vousden KH: Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 65: 891-894, 1992.
31. Czerwenka K, Heuss F, Hosmann JW, Manavi M, Lu Y, Jelincic D and Kubista E: Human papilloma virus DNA: a factor in the pathogenesis of mammary Paget's disease? Breast Cancer Res Treat 41: 51-57, 1996.
32. Gopalkrishna V, Singh UR, Sodhani P, Sharma JK, Hedau ST, Mandal AK, and Das BC: Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 39: 197-202, 1996.
33. Hachana M, Ziadi S, Amara K, Toumi I, Korbi S and Trimeche M: No evidence of human papillomavirus DNA in breast carcinoma in Tunisian patients. Breast 19: 541-544, 2010.
34. Chang P, Wang T, Yao Q, Lv Y, Zhang J, Guo W, Wang L and Chen J: Absence of human papillomavirus in patients with breast cancer in north-west China. Med Oncol 29: 521-525, 2012.
35. Herrera-Romano L, Fernández-Tamayo N, Gómez-Conde E, Reyes-Cardoso JM, Ortiz-Gutierrez F, Ceballos G, Valdivia A, Piña P and Salcedo M: Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population. Med Oncol 29: 1515-1517, 2012.
36. Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, Yan T and Cao C: The role of human papillomavirus infection in breast cancer. Med Oncol 29: 48-55, 2012.
37. Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, Ohi Y, Higashi M Sagara Y, Yoshinaka H, Tsuji T, Natsugoe S, Douchi,T, Eizuru Y and Akiba S. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 99: 408-414, 2008.
38. De Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG, Vidal A, Guimerà N, Cross P, Wain GV, Petry KU, Mariani L, Bergeron C, Mandys V, Sica AR, Félix A, Usubutun A, Seoud M, Hernández-Suárez G, Nowakowski AM, Wilson G, Dalstein V, Hampl M, Kasamatsu ES, Lombardi LE, Tinoco L, Alvarado-Cabrero I, Perrotta M, Bhatla N, Agorastos T, Lynch CF, Goodman MT, Shin HR, Viarheichyk H, Jach R, Cruz MOLE, Velasco J, Molina C, Bornstein J, Ferrera A, Domingo EJ, Chou CY, Banjo AF, Castellsagué X, Pawlita M, Lloveras B, Quint WGV, Muñoz N and Bosch FX: Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 49: 3450-3461, 2013.
39. Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andújar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Muñoz N, Bosch FX and de Sanjosé S: Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention. Gynecol Oncol 124: 512-517, 2012.